Bertil Uggla
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 19
- Acute Myeloid Leukemia Research 14
- Hematopoietic Stem Cell Transplantation 5
-
- Retinoids in leukemia and cellular processes 6
- Co-authors
- Ulf Tidefelt (7 shared papers)Gunnar Juliusson (10 shared papers)Sören Lehmann (9 shared papers)Christer Paul (5 shared papers)Per‐Ola Andersson (5 shared papers)Martin Höglund (11 shared papers)Ove Andrén (1 shared paper)Dina Ali (1 shared paper)
- Journals
- Blood (4 papers)European Journal Of Haematology (4 papers)Haematologica (3 papers)Leukemia Research (2 papers)American Journal of Hematology (2 papers)
- Partner nations
- SwedenAustraliaUnited States
In The Last Decade
Bertil Uggla
30 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 62
- Hematology 558
- Genetics 176
- Oncology 360
- Pathology and Forensic Medicine 147
- Cancer Research 108
Countries citing papers authored by Bertil Uggla
This map shows the geographic impact of Bertil Uggla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bertil Uggla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bertil Uggla more than expected).
Fields of papers citing papers by Bertil Uggla
This network shows the impact of papers produced by Bertil Uggla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bertil Uggla. The network helps show where Bertil Uggla may publish in the future.
Co-authors
The 25 scholars most cited alongside Bertil Uggla, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 333 | |
| 2 | 2014 | 181 | |
| 3 | 2014 | 123 | |
| 4 | 2004 | 88 | |
| 5 | 2011 | 64 | |
| 6 | 2017 | 62 | |
| 7 | Antithymocyte globulin and cyclosporine A as combination therapy for low-risk non-sideroblastic myelodysplastic syndromes. | 2006 | 57 |
| 8 | 2014 | 43 | |
| 9 | 2017 | 42 | |
| 10 | 2018 | 16 | |
| 11 | 2015 | 16 | |
| 12 | 2022 | 15 | |
| 13 | CRIM1 is expressed at higher levels in drug-resistant than in drug-sensitive myeloid leukemia HL60 cells. | 2010 | 15 |
| 14 | Rapid induction of P-glycoprotein mRNA and protein expression by cytarabine in HL-60 cells. | 2009 | 14 |
| 15 | 2014 | 13 | |
| 16 | 2021 | 11 | |
| 17 | 2014 | 11 | |
| 18 | 2017 | 11 | |
| 19 | 2003 | 9 | |
| 20 | 2014 | 9 |
About Bertil Uggla
Bertil Uggla is a scholar working on Hematology, Molecular Biology, Genetics, Oncology and Public Health, Environmental and Occupational Health, having authored 31 papers that have together received 1.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (14 papers), Retinoids in leukemia and cellular processes (6 papers), Hematopoietic Stem Cell Transplantation (5 papers), Acute Lymphoblastic Leukemia research (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Cancer Genomics and Diagnostics (2 papers) and Polyomavirus and related diseases (2 papers). The work is most often cited by research in Hematology (558 citations), Genetics (176 citations), Oncology (360 citations), Pathology and Forensic Medicine (147 citations) and Cancer Research (108 citations). Bertil Uggla has collaborated with scholars based in Sweden, Australia and United States. Frequent co-authors include Ulf Tidefelt, Gunnar Juliusson, Sören Lehmann, Christer Paul, Per‐Ola Andersson, Martin Höglund, Ove Andrén, Dina Ali, Ali Moshfegh and Vladimir J.N. Bykov. Their work appears in journals such as Blood, European Journal Of Haematology, Haematologica, Leukemia Research and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.